Category Archives: People

Nadula Highlights Protective Hairstyles Following This Year’s ESSENCE Festival

SANTA FE SPRINGS, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Launched in 1995 as a one-time event to celebrate the 25th anniversary of Essence magazine, the Essence Festival has evolved into a major annual gathering. Often described as “a party with a purpose,” the festival is dedicated to promoting, celebrating, and discussing a wide range […]

Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion

Delivered strong Q3 financial results: Generated $31.8 million in total net revenues, $13.4 million in gross profit before fair value adjustments, or 42% of revenues, $8.5 million in adjusted EBITDA1, and $5.7 million in operating cash flow. Expanded national distribution and retail penetration: Cannara products exceeded 49,000 points of distribution as of June 2026 and represented […]

Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn

RALEIGH, N.C., July 15, 2026 (GLOBE NEWSWIRE) — Slate Medicines (Slate), a privately-held biotech company advancing next-generation therapeutics for migraine and other headache disorders, today announced the appointment of Mark W. Hahn to the company’s Board of Directors. Mr. Hahn brings more than 25 years of leadership experience building and scaling life sciences companies. “We […]

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

RT-114 achieved systemic exposure greater than 150% relative to a matched 12mg subcutaneous dose of PG-102 No adverse events attributed to RaniPill Capsule; treatment-related adverse events were mild and consistent with the GLP-1/GLP-2 agonist class of therapeutics Phase 1a study expanded with an additional cohort to further define the oral-to-subcutaneous pharmacokinetic relationship ahead of a […]

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

 Patients with restrictive lung disease demonstrate clinically meaningful benefit in FVC and improvements in multiple PROs for 5.0 mg/kg efzofitimod compared to placebo. Company submitted protocol to FDA in June 2026 for planned Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease. SAN DIEGO, July 15, 2026 (GLOBE […]

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

LA JOLLA, Calif., July 15, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the target enrollment of 200 patients has been achieved in the SEANOBI-ALS study (Scalable Expanded Access with Analysis […]

UFV’s Peace and Reconciliation Centre earns international award for community partnership

PARC receives Silver CASE Circle of Excellence Award and is recognized as the highest-ranked initiative from Western Canada and the Pacific Northwest in its category. Chilliwack, B.C., July 14, 2026 (GLOBE NEWSWIRE) — The University of the Fraser Valley’s Peace and Reconciliation Centre (PARC) has been recognized internationally for its ongoing success creating partnerships with Indigenous communities.   The Council for Advancement […]

Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner

Organisations join forces for “a healthier, more productive nation” Agreement with Team GB covers the Los Angeles 2028 Olympic Games LONDON, July 15, 2026 (GLOBE NEWSWIRE) — Spire Healthcare today announces a new strategic partnership with Team GB, becoming the team’s exclusive Official Healthcare Services Partner through to the end of 2028, including the Los […]

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company […]